Artificial intelligence applications in oxaliplatin-based chemotherapy for colon cancer: advancing prognosis, toxicity prediction, and dose personalization.

Jammoul D, Ajibuwa F, Jammoul M, Schlosser-Hupf S, Müller M, El-Najjar N

Open source

DOI
10.3389/fphar.2026.1784272
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1784272,
  title = {Artificial intelligence applications in oxaliplatin-based chemotherapy for colon cancer: advancing prognosis, toxicity prediction, and dose personalization.},
  author = {Jammoul D and Ajibuwa F and Jammoul M and Schlosser-Hupf S and Müller M and El-Najjar N},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1784272},
  url = {https://doi.org/10.3389/fphar.2026.1784272}
}

RIS

TY  - JOUR
TI  - Artificial intelligence applications in oxaliplatin-based chemotherapy for colon cancer: advancing prognosis, toxicity prediction, and dose personalization.
AU  - Jammoul D
AU  - Ajibuwa F
AU  - Jammoul M
AU  - Schlosser-Hupf S
AU  - Müller M
AU  - El-Najjar N
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1784272
UR  - https://doi.org/10.3389/fphar.2026.1784272
ER  - 

APA

D, J., F, A., M, J., S, S., M, M., & N, E. (2026). Artificial intelligence applications in oxaliplatin-based chemotherapy for colon cancer: advancing prognosis, toxicity prediction, and dose personalization.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1784272

Source records